KIT and gastrointestinal stromal tumor: All amidated derivatives showed potent inhibitory activity for mutant-KIT (GIST-T1 and T1-D816E) and T1-a-D842V cell lines in the low double-digit nM range while exhibiting significantly lower inhibitory activity toward the control cell lines compared to avapritinib.